Revance Therapeu Shares Up 23.9% Since SmarTrend's Buy Recommendation (RVNC)

SmarTrend identified an Uptrend for Revance Therapeu (NASDAQ:RVNC) on November 30th, 2017 at $27.42. In approximately 2 months, Revance Therapeu has returned 23.88% as of today's recent price of...